Research progress on antiplatelet therapy in special populations of acute coronary syndrome

doi:10.3969/j.issn.1004-583X.2018.09.006

Abstract

Abstract: Antiplatelet therapy is the cornerstone of the treatment for patients with acute coronary syndrome (ACS), and aspirin combined with a P2Y12 receptor inhibitor is currently the I recommendation in the guidelines. Antiplatelet therapy increases the risk of bleeding while reducing major cardiovascular adverse events in ACS patients. Therefore, for some special populations such as advanced age, diabetes, stroke/TIA, and STEMI patients receiving thrombolysis, the antiplatelet therapy regimen and duration are presenting huge individual differences while evaluating the ischemia risk and bleeding risk. This article reviews the current research progress of antiplatelet therapy in these special populations.

Key words: acute coronary syndrome, anticoagulants, myocardial infarction；aged

Li Liang Wang Mei. Research progress on antiplatelet therapy in special populations of acute coronary syndrome[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2018.09.006.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2018.09.006

https://huicui.hebmu.edu.cn/EN/Y2018/V33/I9/767

[1]	Ma Jinghong, Yang Qian, Jia Yongjian, Dang Yi. Risks of cardiac tamponade resulting from uninterrupted novel oral anticoagulants and uninterrupted warfarin during perioperative period of catheter ablation of atrial fibrillation: A meta-analysis [J]. Clinical Focus, 2022, 37(9): 773-778.
[2]	Li Heng, Li Yonghui, Sun Xiaoqiang, Wang Lin, He Feng. Efficacy and safety of anticoagulant therapy for patients with heart failure in sinus rhythm [J]. Clinical Focus, 2022, 37(5): 406-411.
[3]	Li Jianqin, Sheng Yueyue, Zhou Yinmin, Shi Weiqing, Yang Xingchen. Safety of clopidogrel combined with statins on acute coronary syndrome in patients based on metabolic pathways by different cytochrome P450 enzyme: a Meta analysis [J]. Clinical Focus, 2022, 37(2): 101-105.
[4]	Cui Guoyan, Zheng Wen, Zhang Liwei. Clinical efficacy of lidocaine combined with rosuvastatin in treating acute coronary syndrome concurrent with acute arrhythmia among patients intolerant of amiodarone [J]. Clinical Focus, 2021, 36(4): 311-314.
[5]	Liu Yuanliang, Li Biao, Jiang Zuofeng, Zhu Youfeng, Zhang Shaoheng, Wang Yarong, Li Rongseng, Li Li. Efficacy and safety of half-dose versus standard-dose of tirofiban for percutaneous coronary intervention in elderly Chinese patients with acute coronary syndrome: a meta-analysis [J]. Clinical Focus, 2021, 36(11): 965-971.
[6]	Geng Yanping, Wang Lili, Gu Jian, Qi Peng, Chen Shuxia. Validity and reliability analysis of Chinese version of AntiClot Treatment Scale [J]. Clinical Focus, 2020, 35(9): 788-791.
[7]	Qiu Siyue1, Yang Haiyu2, Yu Tao2, Huang Zhichao1, Zhang Zixin1. Impact of estimated glomerular filtration rate on nosocomial prognosis in patients with acute coronary syndrome [J]. Clinical Focus, 2020, 35(6): 498-502.
[8]	Zhang Han, Shi Yunke, Zhang Min, Cai Hongyan, Li Jian, . The influence of family stress on the quality of life and physical recovery of male and female patients with acute coronary syndrome [J]. Clinical Focus, 2020, 35(12): 1078-1083.
[9]	He Zhengfei, Wang Diqing, He Xiaolan, Sun Linggang. Related factors of slow coronary flowno reflow after percutaneous coronary angioplasty for acute coronary syndrome [J]. Clinical Focus, 2020, 35(11): 971-975.
[10]	Rao Mingyue, Wang Yaling, Zhang Guoru, Wang Mei. Advances in anticoagulant therapy after acute coronary syndrome [J]. Clinical Focus, 2018, 33(9): 761-766.
[11]	Xia Jinggang， Xu Ji， Hao Hengjian， Yin Chunlin， Xu Dong. Relationship between apolipoprotein E gene polymorphism and shortterm prognosis in patients with acute coronary syndrome [J]. Clinical Focus, 2017, 32(7): 579-582.
[12]	Pan Guangjie，Chen Huili，Gu Yunfei，Liu Lei，Chen Yan，Li Songsen，Ma Huifang，Jin Jun，Zhang Shouyan. Current situation and related factors of coronary intervention treatment in patients with non STelevation acute coronary syndrome [J]. Clinical Focus, 2017, 32(7): 591-594.
[13]	Teng Xin1， Qin Qin2， Lu Yaru2， Yang Ning2. Relation between platelet parameters and clinical classification and severity of acute coronary syndrome [J]. Clinical Focus, 2017, 32(6): 487-490.
[14]	Liu Xiaoyu，Jia Guowei，Sun Rongguo，Ma Bocong，Zhao Ming，Zhang Hongbin，Zhang Wei. Ticagrelor and clopidogrel on PCI perioperative hsCRP in patients with acute coronary syndrome [J]. Clinical Focus, 2017, 32(5): 421-424.
[15]	Wang Yanbo，Gu Xinshun，Hao Guozhen，Jiang Yunfa，Fan Weize，Fu Xianghua. Incidence and risk factors of type 1 cardiorenal syndrome in patients with acute coronary syndrome [J]. Clinical Focus, 2017, 32(4): 310-313.

Research progress on antiplatelet therapy in special populations of acute coronary syndrome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments